82 FR 11931 - Office of the Director, National Institutes of Health; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 82, Issue 37 (February 27, 2017)

Page Range		11931-11932
FR Document		2017-03814

Federal Register, Volume 82 Issue 37 (Monday, February 27, 2017)

[Federal Register Volume 82, Number 37 (Monday, February 27, 2017)]
[Notices]
[Pages 11931-11932]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-03814]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, National Institutes of Health; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
Advisory Committee to the Director, National Institutes of Health.
    The meeting will be held as a teleconference call only and is open 
to the public to dial-in for participation.

[[Page 11932]]

Individuals who plan to dial-in to the meeting and need special 
assistance or other reasonable accommodations in order to do so, should 
notify the Contact Person listed below in advance of the meeting.

    Name of Committee: Advisory Committee to the Director, National 
Institutes of Health.
    Date: March 28, 2017.
    Time: 3:00 p.m. to 5:00 p.m.
    Agenda: HeLa Working Group report; Review of IC work plans in 
accordance with the 21st Century Cures Act.
    Place: National Institutes of Health, Building 1, One Center 
Drive, Bethesda, MD 20892 (Telephone Conference Call), 800-857-4891, 
Access Code: 7845444.
    Contact Person: Gretchen Wood, Staff Assistant, National 
Institutes of Health, Office of the Director, One Center Drive, 
Building 1, Room 126, Bethesda, MD 20892, 301-496-4272, 
[email protected].
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: http://acd.od.nih.gov, where an agenda and any additional 
information for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.14, 
Intramural Research Training Award; 93.22, Clinical Research Loan 
Repayment Program for Individuals from Disadvantaged Backgrounds; 
93.232, Loan Repayment Program for Research Generally; 93.39, 
Academic Research Enhancement Award; 93.936, NIH Acquired 
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187, 
Undergraduate Scholarship Program for Individuals from Disadvantaged 
Backgrounds, National Institutes of Health, HHS)


    Dated: February 22, 2017.
Anna Snouffer,
 Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-03814 Filed 2-24-17; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 37 / Monday, February 27, 2017 / Notices 11931

Scientific Review, National Institutes of Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND
Health, 6701 Rockledge Drive, Room 5108, applications. HUMAN SERVICES
MSC 7852, Bethesda, MD 20892, (301) 435– Place: National Institutes of Health, 6701
1168, montalve@csr.nih.gov. Rockledge Drive, Bethesda, MD 20892 National Institutes of Health
Name of Committee: Center for Scientific (Virtual Meeting).
Review Special Emphasis Panel; Small Contact Person: Mike Radtke, Ph.D., National Human Genome Research
Business: Risk, Prevention and Health Scientific Review Officer, Center for Institute; Notice of Closed Meeting
Behavior. Scientific Review, National Institutes of
Date: March 23–24, 2017. Health, 6701 Rockledge Drive, Room 4176, Pursuant to section 10(d) of the
Time: 8:00 a.m. to 5:00 p.m. MSC 7806, Bethesda, MD 20892, 301–435– Federal Advisory Committee Act, as
Agenda: To review and evaluate grant 1728, radtkem@csr.nih.gov. amended (5 U.S.C. App.), notice is
applications. Name of Committee: Center for Scientific hereby given of the following meeting.
Place: The Westgate Hotel, 1055 Second Review Special Emphasis Panel; RFA–RM– The meeting will be closed to the
Avenue, San Diego, CA 92101. 16–020: Facile Methods and Technologies for
Contact Person: Claire E. Gutkin, Ph.D., public in accordance with the
Synthesis of Biomedically Relevant provisions set forth in sections
MPH, Scientific Review Officer, Center for Carbohydrates.
Scientific Review, National Institutes of 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Date: March 23, 2017.
Health, 6701 Rockledge Drive, Room 3106, Time: 11:00 a.m. to 5:00 p.m. as amended. The grant applications and
MSC 7808, Bethesda, MD 20892, 301–594– Agenda: To review and evaluate grant the discussions could disclose
3139, gutkincl@csr.nih.gov. applications. confidential trade secrets or commercial
Name of Committee: Center for Scientific Place: National Institutes of Health, 6701 property such as patentable material,
Review Special Emphasis Panel; Exploration Rockledge Drive, Bethesda, MD 20892. and personal information concerning
of Antimicrobial Resistant Microbes and Contact Person: Michael Eissenstat, Ph.D., individuals associated with the grant
Antimicrobial Therapeutics. Scientific Review Officer, BCMB IRG, Center applications, the disclosure of which
Date: March 23–24, 2017. for Scientific Review, National Institutes of
Time: 8:00 a.m. to 6:00 p.m. would constitute a clearly unwarranted
Health, 6701 Rockledge Drive, Room 4166, invasion of personal privacy.
Agenda: To review and evaluate grant Bethesda, MD 20892, 301–435–1722,
applications. eissenstatma@csr.nih.gov. Name of Committee: National Human
Place: Doubletree Hotel Bethesda, 8120 Genome Research Institute Special Emphasis
Wisconsin Avenue, Bethesda, MD 20814. Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in Panel; CIDR Conflict.
Contact Person: Susan Daum, Ph.D., Date: March 15, 2017.
Scientific Review Officer, Center for Drug Discovery and Mechanisms of
Time: 12:00 p.m. to 2:00 p.m.
Scientific Review, National Institutes of Antimicrobial Resistance.
Agenda: To review and evaluate grant
Health, 6701 Rockledge Dr. Room 3202, Date: March 23, 2017.
applications.
Bethesda, md 20892, susan.boyle-vavra@ Time: 1:15 p.m. to 2:15 p.m.
Place: National Human Genome Research
nih.gov. Agenda: To review and evaluate grant
Institute, National Institutes of Health, 5635
applications.
Name of Committee: Center for Scientific Fisher Lane, Suite 3056, 3rd Floor, Rockville,
Place: Doubletree Hotel Bethesda, 8120
Review Special Emphasis Panel; RFA Panel: MD, (Telephone Conference Call).
Wisconsin Avenue, Bethesda, MD 20814.
PREP Engagement and Retention among Contact Person: Ken D. Nakamura, Ph.D.,
Contact Person: Guangyong Ji, Ph.D.,
Populations at High Risk for HIV Infection. Scientific Review Officer, Scientific Review
Scientific Review Officer, Center for
Date: March 23–24, 2017. Branch, National Human Genome Research
Scientific Review, National Institutes of
Time: 8:00 a.m. to 5:00 p.m. Institute, National Institutes of Health, 5635
Health, 6701 Rockledge Drive, Room 3211, Fishers Lane, Suite 4076, MSC 9306,
Agenda: To review and evaluate grant
applications. MSC 7808, Bethesda, MD 20892, 301–435– Rockville, MD 20852, 301–402–0838,
Place: Washington Marriott Georgetown, 1146, jig@csr.nih.gov. nakamurk@mail.nih.gov.
1221 22nd Street NW., Washington, DC Name of Committee: Center for Scientific (Catalogue of Federal Domestic Assistance
20037. Review Special Emphasis Panel; PAR Panel: Program Nos. 93.172, Human Genome
Contact Person: Shalanda A. Bynum, Metabolic Reprogramming to Improve Research, National Institutes of Health, HHS)
Ph.D., MPH, Scientific Review Officer, Center Immunotherapy.
for Scientific Review, National Institutes of Date: March 23, 2017. Dated: February 21, 2017.
Health, 6701 Rockledge Drive, Room 3206, Time: 12:00 p.m. to 4:00 p.m. Sylvia L. Neal,
Bethesda, MD 20892, 301–755–4355, Agenda: To review and evaluate grant Program Analyst, Office of Federal Advisory
bynumsa@csr.nih.gov. applications. Committee Policy.
Name of Committee: Center for Scientific Place: National Institutes of Health, 6701
[FR Doc. 2017–03717 Filed 2–24–17; 8:45 am]
Review Special Emphasis Panel; Rockledge Drive, Bethesda, MD 20892,
(Telephone Conference Call). BILLING CODE 4140–01–P
Fellowships: Physiology and Pathobiology of
Cardiovascular and Respiratory Systems. Contact Person: Denise R. Shaw, Ph.D.,
Date: March 23–24, 2017. Scientific Review Officer, Center for
Scientific Review, National Institutes of DEPARTMENT OF HEALTH AND
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant Health, 6701 Rockledge Drive, Room 6158, HUMAN SERVICES
applications. MSC 7804, Bethesda, MD 20892, 301–435–
Place: Embassy Suites at the Chevy Chase 0198, shawdeni@csr.nih.gov. National Institutes of Health
Pavilion, 4300 Military Road NW., (Catalogue of Federal Domestic Assistance
Washington, DC 20015. Program Nos. 93.306, Comparative Medicine; Office of the Director, National
Contact Person: Eugene Carstea, Ph.D., 93.333, Clinical Research, 93.306, 93.333, Institutes of Health; Notice of Meeting
Scientific Review Officer, Center for 93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Pursuant to section 10(a) of the
Scientific Review, National Institutes of
Federal Advisory Committee Act, as
mstockstill on DSK3G9T082PROD with NOTICES

Health, 6701 Rockledge Drive, Room 4130, Institutes of Health, HHS)
MSC 7818, Bethesda, MD 20892, (301) 408– amended (5 U.S.C. App.), notice is
Dated: February 21, 2017. hereby given of a meeting of the
9756, carsteae@csr.nih.gov.
Michelle Trout, Advisory Committee to the Director,
Name of Committee: Center for Scientific
Program Analyst, Office of Federal Advisory National Institutes of Health.
Review Special Emphasis Panel; BCMB
Committee Policy. The meeting will be held as a
Continuous Submission and Conflict Review.
Date: March 23, 2017. [FR Doc. 2017–03707 Filed 2–24–17; 8:45 am] teleconference call only and is open to
Time: 10:00 a.m. to 4:00 p.m. BILLING CODE 4140–01–P the public to dial-in for participation.

VerDate Sep<11>2014 20:23 Feb 24, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\27FEN1.SGM 27FEN1

11932 Federal Register / Vol. 82, No. 37 / Monday, February 27, 2017 / Notices

Individuals who plan to dial-in to the the discussions could disclose applications, the disclosure of which
meeting and need special assistance or confidential trade secrets or commercial would constitute a clearly unwarranted
other reasonable accommodations in property such as patentable material, invasion of personal privacy.
order to do so, should notify the Contact and personal information concerning Name of Committee: National Institute of
Person listed below in advance of the individuals associated with the contract General Medical Sciences Special Emphasis
meeting. proposals, the disclosure of which Panel Review of R24 Applications.
Name of Committee: Advisory Committee would constitute a clearly unwarranted Date: March 10, 2017.
to the Director, National Institutes of Health. invasion of personal privacy. Time: 1:00 p.m. to 5:00 p.m.
Date: March 28, 2017. Agenda: To review and evaluate grant
Name of Committee: National Cancer applications.
Time: 3:00 p.m. to 5:00 p.m. Institute Special Emphasis Panel Innovative Place: National Institutes of Health,
Agenda: HeLa Working Group report; Manufacturing of Cell-Based Natcher Building, 2as 10, 45 Center Drive,
Review of IC work plans in accordance with Immunotherapies for Oncology. Bethesda, MD 20892.
the 21st Century Cures Act. Date: March 8, 2017. Contact Person: Saraswathy Seetharam,
Place: National Institutes of Health, Time: 10:00 a.m. to 6:00 p.m. Ph.D., Scientific Review Officer, Office
Building 1, One Center Drive, Bethesda, MD Agenda: To review and evaluate contract Scientific Review, National Institute of
20892 (Telephone Conference Call), 800– proposals. General Medical Sciences, National Institutes
857–4891, Access Code: 7845444. Place: National Cancer Institute Shady Health, 45 Center Drive, Room 3AN12C,
Contact Person: Gretchen Wood, Staff Grove 9609 Medical Center Drive, Room Bethesda, MD 20892, 301–594–2763,
Assistant, National Institutes of Health, 2W904 Rockville, MD 20850 (Telephone seetharams@nigms.nih.gov.
Office of the Director, One Center Drive, Conference Call). This notice is being published less than 15
Building 1, Room 126, Bethesda, MD 20892, Contact Person: Reed A. Graves, Ph.D., days prior to the meeting due to the timing
301–496–4272, Woodgs@od.nih.gov. Scientific Review Officer, Research limitations imposed by the review and
Any interested person may file written Technology and Contract Review Branch, funding cycle.
comments with the committee by forwarding Division of Extramural Activities, National
the statement to the Contact Person listed on (Catalogue of Federal Domestic Assistance
Cancer Institute, NIH, 9609 Medical Center Program Nos. 93.375, Minority Biomedical
this notice. The statement should include the Drive, Room 7W106, Bethesda, MD 20892–
name, address, telephone number and when Research Support; 93.821, Cell Biology and
9750, 240–276–6384, gravesr@mail.nih.gov. Biophysics Research; 93.859, Pharmacology,
applicable, the business or professional
affiliation of the interested person. This notice is being published less than 15 Physiology, and Biological Chemistry
Information is also available on the days prior to the meeting due to the timing Research; 93.862, Genetics and
limitations imposed by the review and Developmental Biology Research; 93.88,
Institute’s/Center’s home page: http://
funding cycle. Minority Access to Research Careers; 93.96,
acd.od.nih.gov, where an agenda and any
(Catalogue of Federal Domestic Assistance Special Minority Initiatives; 93.859,
additional information for the meeting will
Program Nos. 93.392, Cancer Construction; Biomedical Research and Research Training,
be posted when available.
93.393, Cancer Cause and Prevention National Institutes of Health, HHS)
(Catalogue of Federal Domestic Assistance
Research; 93.394, Cancer Detection and Dated: February 22, 2017.
Program Nos. 93.14, Intramural Research
Diagnosis Research; 93.395, Cancer Melanie J. Pantoja,
Training Award; 93.22, Clinical Research
Treatment Research; 93.396, Cancer Biology
Loan Repayment Program for Individuals Program Analyst, Office of Federal Advisory
Research; 93.397, Cancer Centers Support;
from Disadvantaged Backgrounds; 93.232, Committee Policy.
93.398, Cancer Research Manpower; 93.399,
Loan Repayment Program for Research [FR Doc. 2017–03821 Filed 2–24–17; 8:45 am]
Cancer Control, National Institutes of Health,
Generally; 93.39, Academic Research
HHS) BILLING CODE 4140–01–P
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Dated: February 22, 2017.
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from Melanie J. Pantoja, DEPARTMENT OF HEALTH AND
Disadvantaged Backgrounds, National Program Analyst, Office of Federal Advisory HUMAN SERVICES
Institutes of Health, HHS) Committee Policy.
[FR Doc. 2017–03820 Filed 2–24–17; 8:45 am] National Institutes of Health
Dated: February 22, 2017. BILLING CODE 4140–01–P
Anna Snouffer, National Library of Medicine; Notice of
Deputy Director, Office of Federal Advisory Meetings
Committee Policy. DEPARTMENT OF HEALTH AND Pursuant to section 10(d) of the
[FR Doc. 2017–03814 Filed 2–24–17; 8:45 am] HUMAN SERVICES Federal Advisory Committee Act, as
BILLING CODE 4140–01–P amended (5 U.S.C. App), notice is
National Institutes of Health hereby given of meetings of the Board of
National Institute of General Medical Regents of the National Library of
DEPARTMENT OF HEALTH AND Medicine.
HUMAN SERVICES Sciences; Notice of Closed Meeting
The meeting will be open to the
Pursuant to section 10(d) of the public as indicated below, with
National Institutes of Health Federal Advisory Committee Act, as attendance limited to space available.
amended (5 U.S.C. App.), notice is Individuals who plan to attend and
National Cancer Institute; Notice of
hereby given of the following meeting. need special assistance, such as sign
Closed Meetings The meeting will be closed to the language interpretation or other
Pursuant to section 10(d) of the public in accordance with the reasonable accommodations, should
Federal Advisory Committee Act, as provisions set forth in sections notify the Contact Person listed below
mstockstill on DSK3G9T082PROD with NOTICES

amended (5 U.S.C. App.), notice is 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., in advance of the meeting.
hereby given of the following meetings. as amended. The grant applications and The meeting will be closed to the
The meetings will be closed to the the discussions could disclose public in accordance with the
public in accordance with the confidential trade secrets or commercial provisions set forth in sections
provisions set forth in sections property such as patentable material, 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., and personal information concerning as amended. The grant applications and
as amended. The contract proposals and individuals associated with the grant the discussions could disclose

VerDate Sep<11>2014 20:23 Feb 24, 2017 Jkt 241001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\27FEN1.SGM 27FEN1

Document Created: 2017-02-25 01:05:56
Document Modified: 2017-02-25 01:05:56

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 28, 2017.
FR Citation		82 FR 11931